| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1478-3231.2011.02597.X |
| P698 | PubMed publication ID | 21955977 |
| P50 | author | John M. Luk | Q42935545 |
| Ching-Lung Lai | Q56885069 | ||
| Man-Fung Yuen | Q59187364 | ||
| Irene Oi-lin Ng | Q67487913 | ||
| Ronnie Tung-Ping Poon | Q114575699 | ||
| P2093 | author name string | Hongyue Dai | |
| Chunsheng Zhang | |||
| Heng Zhao | |||
| Jin-jun Li | |||
| Sarwat Fatima | |||
| Edmund Kwok-Kwan Tung | |||
| Regina Cheuk-Lam Lo | |||
| Carmen Ka-Man Mak | |||
| P2860 | cites work | Isolation and biochemical characterization of the human Dkk-1 homologue, a novel inhibitor of mammalian Wnt signaling | Q22010178 |
| Functional and structural diversity of the human Dickkopf gene family | Q22010830 | ||
| Novel mechanism of Wnt signalling inhibition mediated by Dickkopf-1 interaction with LRP6/Arrow | Q24291392 | ||
| Head inducer Dickkopf-1 is a ligand for Wnt coreceptor LRP6 | Q24291433 | ||
| Global cancer statistics, 2002 | Q27860562 | ||
| LDL-receptor-related protein 6 is a receptor for Dickkopf proteins | Q28116567 | ||
| DKK1, a negative regulator of Wnt signaling, is a target of the beta-catenin/TCF pathway | Q28283034 | ||
| Expression of Dickkopf genes is strongly reduced in malignant melanoma | Q28304142 | ||
| Dickkopf-1 is a member of a new family of secreted proteins and functions in head induction | Q29616164 | ||
| Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma | Q33947429 | ||
| Serum tumor markers for detection of hepatocellular carcinoma | Q34501851 | ||
| Dickkopf-1 expression increases early in prostate cancer development and decreases during progression from primary tumor to metastasis | Q35679829 | ||
| Dickkopf-1 is an epigenetically silenced candidate tumor suppressor gene in medulloblastoma | Q35799986 | ||
| Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature | Q35810123 | ||
| Dickkopf-1 (DKK1) is a widely expressed and potent tumor-associated antigen in multiple myeloma | Q35989451 | ||
| Dysregulation of growth factor signaling in human hepatocellular carcinoma. | Q36519010 | ||
| The Wnt pathway regulator DKK1 is preferentially expressed in hormone-resistant breast tumours and in some common cancer types | Q36609873 | ||
| Molecular therapy for the treatment of hepatocellular carcinoma | Q37329048 | ||
| Dikkopf-1 as a novel serologic and prognostic biomarker for lung and esophageal carcinomas | Q38433460 | ||
| Wnt inhibitor Dickkopf-1 as a target for passive cancer immunotherapy | Q39692668 | ||
| Elevated expression of DKK1 is associated with cytoplasmic/nuclear beta-catenin accumulation and poor prognosis in hepatocellular carcinomas | Q39870072 | ||
| Dickkopf-1 enhances migration of HEK293 cell by beta-catenin/E-cadherin degradation | Q39875228 | ||
| Rho-kinase 2 is frequently overexpressed in hepatocellular carcinoma and involved in tumor invasion. | Q39885550 | ||
| HAI-2 is epigenetically downregulated in human hepatocellular carcinoma, and its Kunitz domain type 1 is critical for anti-invasive functions. | Q39901768 | ||
| Dickkopf-1 expression as a marker for predicting clinical outcome in esophageal squamous cell carcinoma | Q39983229 | ||
| Serum concentrations of DKK-1 decrease in patients with multiple myeloma responding to anti-myeloma treatment | Q43844308 | ||
| Dickkopf-1 Enhances Inflammatory Interaction Between Platelets and Endothelial Cells and Shows Increased Expression in Atherosclerosis | Q57315838 | ||
| Serum concentrations of Dickkopf-1 protein are increased in patients with multiple myeloma and reduced after autologous stem cell transplantation | Q57904871 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1494-1504 | |
| P577 | publication date | 2011-08-04 | |
| P1433 | published in | Liver International | Q15765078 |
| P1476 | title | Clinicopathological and prognostic significance of serum and tissue Dickkopf-1 levels in human hepatocellular carcinoma | |
| P478 | volume | 31 |
| Q88437961 | A qualitative signature for early diagnosis of hepatocellular carcinoma based on relative expression orderings |
| Q90300594 | APEX1 is a novel diagnostic and prognostic biomarker for hepatocellular carcinoma |
| Q26799462 | Biological features and biomarkers in hepatocellular carcinoma |
| Q38450711 | Biomarkers for hepatocellular carcinoma: diagnostic and therapeutic utility. |
| Q92029806 | Circular RNA circRHOT1 promotes hepatocellular carcinoma progression by initiation of NR2F6 expression |
| Q39009372 | Clinical significance and diagnostic value of serum dickkopf-1 in patients with hepatocellular carcinoma |
| Q42544189 | Comprehensive analysis of normal adjacent to tumor transcriptomes |
| Q53708414 | Cripto-1 contributes to stemness in hepatocellular carcinoma by stabilizing Dishevelled-3 and activating Wnt/β-catenin pathway. |
| Q38366584 | Current biomarkers for hepatocellular carcinoma: Surveillance, diagnosis and prediction of prognosis |
| Q39044797 | DKK1 promotes hepatocellular carcinoma cell migration and invasion through β-catenin/MMP7 signaling pathway |
| Q91584626 | Data mining of the expression and regulatory role of BCAT1 in hepatocellular carcinoma |
| Q92495121 | Diagnostic accuracy of serum dickkopf-1 protein in diagnosis hepatocellular carcinoma: An updated meta-analysis |
| Q86659636 | Diagnostic values of alpha-fetoprotein, dickkopf-1, and osteopontin for hepatocellular carcinoma |
| Q39411411 | Dickkopf 4 (DKK4) acts on Wnt/β-catenin pathway by influencing β-catenin in hepatocellular carcinoma |
| Q41708730 | Dickkopf-1 induces angiogenesis via VEGF receptor 2 regulation independent of the Wnt signaling pathway. |
| Q34306010 | Diverse modes of genomic alteration in hepatocellular carcinoma |
| Q38210247 | Dysregulated expression of dickkopfs for potential detection of hepatocellular carcinoma. |
| Q30662860 | Elucidation of how cancer cells avoid acidosis through comparative transcriptomic data analysis. |
| Q53388123 | Evolving-Pattern Analysis of Transient and Long-Term Biomarkers for Cancers: Hepatocellular Carcinoma as a Case. |
| Q53615601 | Evolving-pattern analysis of transient and long-term biomarkers for cancers: Hepatocellular carcinoma as a case. |
| Q92906482 | Gastric Normal Adjacent Mucosa Versus Healthy and Cancer Tissues: Distinctive Transcriptomic Profiles and Biological Features |
| Q37708316 | Identification and interaction analysis of key genes and microRNAs in hepatocellular carcinoma by bioinformatics analysis |
| Q27310913 | Identification of Chemical Inhibitors of β-Catenin-Driven Liver Tumorigenesis in Zebrafish |
| Q93052530 | Identification of Platform-Independent Diagnostic Biomarker Panel for Hepatocellular Carcinoma Using Large-Scale Transcriptomics Data |
| Q55359727 | Identification of key candidate genes and pathways in hepatocellular carcinoma by integrated bioinformatical analysis. |
| Q52564717 | Marker of proliferation Ki-67 expression is associated with transforming growth factor beta 1 and can predict the prognosis of patients with hepatic B virus-related hepatocellular carcinoma. |
| Q41322632 | Meta-analysis of gene expression profiles indicates genes in spliceosome pathway are up-regulated in hepatocellular carcinoma (HCC). |
| Q26745556 | Modulating Dickkopf-1: A Strategy to Monitor or Treat Cancer? |
| Q39313526 | Molecular mechanisms of sorafenib action in liver cancer cells. |
| Q38475203 | Molecular signalling in hepatocellular carcinoma: Role of and crosstalk among WNT/ß-catenin, Sonic Hedgehog, Notch and Dickkopf-1. |
| Q36414017 | Na+/K+-ATPase α1 subunit, a novel therapeutic target for hepatocellular carcinoma |
| Q99406905 | New Blood Biomarkers for the Diagnosis of AFP-Negative Hepatocellular Carcinoma |
| Q53130710 | Prognostic significance of dickkopf-1 overexpression in solid tumors: a meta-analysis. |
| Q39345895 | Rationale for targeting the Wnt signalling modulator Dickkopf-1 for oncology. |
| Q46845924 | Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study |
| Q35971072 | Serum Dickkopf-1 as a Biomarker for the Diagnosis of Hepatocellular Carcinoma. |
| Q92461497 | Serum Dickopff 1 as a Novel Biomarker in Hepatocellular Carcinoma Diagnosis and Follow Up After Ablative Therapy |
| Q39505043 | Significance of serum DKK1 as a diagnostic biomarker in hepatocellular carcinoma |
| Q38849710 | Study of Dickkopf-1 (DKK-1) Gene Expression in Hepatocellular Carcinoma Patients |
| Q98165157 | Study of Dickkopf-1 (DKK-1) in patients with chronic viral hepatitis C-related liver cirrhosis with and without hepatocellular carcinoma |
| Q55401116 | Systems analysis of key genes and pathways in the progression of hepatocellular carcinoma. |
| Q64066145 | Systems biology based meth-miRNA-mRNA regulatory network identifies metabolic imbalance and hyperactive cell cycle signaling involved in hepatocellular carcinoma onset and progression |
| Q38758644 | The MBNL3 splicing factor promotes hepatocellular carcinoma by increasing PXN expression through the alternative splicing of lncRNA-PXN-AS1. |
| Q35423042 | Toxicogenomics directory of chemically exposed human hepatocytes |
| Q64275021 | Upregulated MMP28 in Hepatocellular Carcinoma Promotes Metastasis via Notch3 Signaling and Predicts Unfavorable Prognosis |
| Q36916412 | miR-493 mediated DKK1 down-regulation confers proliferation, invasion and chemo-resistance in gastric cancer cells |
Search more.